Medtronic (MDT) Cash from Operations Growth (1y) (2015 - 2026)

Medtronic (MDT) Cash from Operations Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 181.51 Bn 174.22 Bn 6.27 Bn -7.20%
2 Stryker 128.20 Bn 125.32 Bn 3.81 Bn 132.40%
3 Medtronic 107.69 Bn 98.47 Bn 6.41 Bn 1.78%
4 Boston Scientific 68.05 Bn 66.59 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 47.52 Bn 43.85 Bn 1.29 Bn -84.38%
6 GE HealthCare Technologies 28.46 Bn 26.17 Bn 1.98 Bn 16.00%
7 Dexcom 28.25 Bn 27.13 Bn 750.30 Mn 185.96%
8 Smith & Nephew 26.73 Bn 26.15 Bn - -
9 Koninklijke Philips 25.31 Bn 22.19 Bn 2.07 Bn 122.43%
10 Steris 21.43 Bn 20.99 Bn 697.10 Mn 28.60%

Historic Data

Download Data
DateValue
Apr 24, 2026 1.78%
Jan 23, 2026 6.69%
Oct 24, 2025 -3.44%
Jul 25, 2025 10.34%
Apr 25, 2025 -8.97%
Jan 24, 2025 3.96%
Oct 25, 2024 44.93%
Jul 26, 2024 12.69%
Apr 26, 2024 12.89%
Jan 26, 2024 57.18%
Oct 27, 2023 -28.31%
Jul 28, 2023 -19.21%
Apr 28, 2023 19.59%
Jan 27, 2023 -29.35%
Oct 28, 2022 -47.88%
Jul 29, 2022 -16.18%
Apr 29, 2022 17.88%
Jan 28, 2022 -5.43%
Oct 29, 2021 -4.94%
Jul 30, 2021 364.75%